H. Raftopoulos

Activin receptor antagonists for cancer-related anemia and bone disease

E. Terpos, M. J. Alexander, M. Sherman, 2013, Expert opinion on investigational drugs.

Chemotherapy for Metastatic Renal Cell Carcinoma (RCC)

D. Petrylak, H. Raftopoulos, J. Ruiz, 2000 .

Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases.

Charles A Powell, Gregory D N Pearson, J. Austin, 2007, Radiology.

Histologic Assessment of Non–Small Cell Lung Carcinoma after Neoadjuvant Therapy

A. Borczuk, M. Ginsburg, L. Gorenstein, 2003, Modern Pathology.

Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies

J. Crawford, N. Gabrail, J. Goldschmidt, 2015, Supportive Care in Cancer.

Thrombocytopenia caused by isotretinoin.

W. Bezwoda, B. Mendelow, H. Raftopoulos, 1986, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer

J. Picus, A. Lockhart, D. Berg, 2008, Cancer Chemotherapy and Pharmacology.

Metastatic Solid Tumors

C. Verschraegen, C. Sweeney, K. Feit, 2019 .

Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA – N 2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy †

Ronald, Ramalingam, Igor, 2015 .

Chemotherapy-Induced Nausea and Vomiting

F. Roila, B. Rapoport, H. Raftopoulos, 2015, BioMed research international.